![Pierre Fabre Laboratories erwirbt Vertical Bio und den Kandidaten des Unternehmens für eine innovative zielgerichtete Therapie für Patienten, die an nicht-kleinzelligem Lungenkrebs mit MET-Veränderung leiden Pierre Fabre Laboratories erwirbt Vertical Bio und den Kandidaten des Unternehmens für eine innovative zielgerichtete Therapie für Patienten, die an nicht-kleinzelligem Lungenkrebs mit MET-Veränderung leiden](https://mma.prnewswire.com/media/2205429/Pierre_Fabre_Vertical_Bio_Logo.jpg?p=facebook)
Pierre Fabre Laboratories erwirbt Vertical Bio und den Kandidaten des Unternehmens für eine innovative zielgerichtete Therapie für Patienten, die an nicht-kleinzelligem Lungenkrebs mit MET-Veränderung leiden
![Avene Foundation Avene Fluid Foundation Corrector SPF20 30ml, Hersteller: AVENE (Pierre Fabre It. SpA) Avene Foundation Avene Fluid Foundation Corrector SPF20 30ml, Hersteller: AVENE (Pierre Fabre It. SpA)](https://i.otto.de/i/otto/3ee84004-ccf5-5472-bb79-dd847eb794e7/avene-foundation-avene-fluid-foundation-corrector-spf20-30ml.jpg?$formatz$)
Avene Foundation Avene Fluid Foundation Corrector SPF20 30ml, Hersteller: AVENE (Pierre Fabre It. SpA)
![Pierre Fabre on X: "The EspeRare Foundation and #PierreFabre join forces to develop and market a pioneering treatment for XLHED, a dermatological ultrarare genetic disease that requires prenatal therapeutic intervention. https://t.co/Kapqvu4RpT #Health # Pierre Fabre on X: "The EspeRare Foundation and #PierreFabre join forces to develop and market a pioneering treatment for XLHED, a dermatological ultrarare genetic disease that requires prenatal therapeutic intervention. https://t.co/Kapqvu4RpT #Health #](https://pbs.twimg.com/media/EpM4igPXMAIMdEi.jpg:large)
Pierre Fabre on X: "The EspeRare Foundation and #PierreFabre join forces to develop and market a pioneering treatment for XLHED, a dermatological ultrarare genetic disease that requires prenatal therapeutic intervention. https://t.co/Kapqvu4RpT #Health #
![Foundation Medicine Announces Collaboration with Pierre Fabre Laboratories to Develop Companion Diagnostics in Non-Small Cell Lung Cancer | Business Wire Foundation Medicine Announces Collaboration with Pierre Fabre Laboratories to Develop Companion Diagnostics in Non-Small Cell Lung Cancer | Business Wire](https://mms.businesswire.com/media/20231115525953/en/1944976/23/FMIPierreFabre.jpg)